Get all your news in one place.
100's of premium titles.
One app.
Start reading
Medical Daily
Medical Daily
Dorothy Brooks

Multi Dose Maternal RSV Vaccine Vial Clears WHO Review as American Families Weigh Two Infant Options

The World Health Organization has prequalified a multi-dose vial version of the maternal RSV vaccine, clearing the last regulatory obstacle that had been holding up a funded global rollout aimed at protecting newborns in the countries where RSV kills the most infants.

The decision, announced on September 9, covers the multi-dose presentation of RSVpreF, sold by Pfizer as Abrysvo. Gavi, the vaccine alliance, welcomed the decision and said it paves the way for introduction in lower-income countries with its support.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.